Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EOLS Evolus Inc.

Trading 08-26 11:30:32 EDT

8.98

+0.01

+0.06%

High9.08	Low8.86	Vol373.51K
Open8.86	D1 Closing8.98	Amplitude2.45%
Mkt Cap591.38M	Tradable Cap458.10M	Total Shares65.85M
T/O3.35M	T/O Rate0.73%	Tradable Shares51.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EOLS","market":"US","secType":"STK","nameCN":"Evolus Inc.","latestPrice":8.98,"timestamp":1787758231073,"preClose":8.975,"halted":0,"volume":373508,"delay":0,"changeRate":0.0005571030640669395,"floatShares":51013400,"shares":65854751,"eps":-0.52667,"marketStatus":"Trading","change":0.005,"latestTime":"08-26 11:30:32 EDT","open":8.86,"high":9.08,"low":8.86,"amount":3353893.049028,"amplitude":0.024513,"askPrice":9,"askSize":469,"bidPrice":8.97,"bidSize":2571,"shortable":3,"etf":0,"ttmEps":-0.52667,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1518066000000,"exchange":"NASDAQ","adjPreClose":8.975,"preHourTrading":{"tag":"盘前","latestPrice":8.62,"preClose":8.975,"latestTime":"09:25 EDT","volume":1232,"amount":10924.540704,"timestamp":1787750700289,"change":-0.355,"changeRate":-0.039554,"amplitude":0.047911},"postHourTrading":{"tag":"盘后","latestPrice":9,"preClose":8.975,"latestTime":"19:57 EDT","volume":18110,"amount":162561.105,"timestamp":1787702252475,"change":0.025,"changeRate":0.002786,"amplitude":0.002786},"volumeRatio":1.129959,"impliedVol":0.7383,"impliedVolPercentile":0.2908},"requestUrl":"/m/hq/s/EOLS","defaultTab":"news","newsList":[{"id":"2662734541","title":"Evolus Price Target Maintained with a $13.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734541?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:06","pubTimestamp":1787659560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EOLS/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659161886","title":"August 2026's Leading Growth Companies With Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2659161886","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659161886?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:05","pubTimestamp":1786640738,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 1.0%, contributing to an impressive 18% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this thriving environment, growth companies with high insider ownership stand out as they often reflect strong internal confidence and alignment with shareholder interests.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7132000-choice1-main-header/1585186724276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-bull/webull/news/august-2026s-leading-growth-companies-with-insider-confidenc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-bull/webull/news/august-2026s-leading-growth-companies-with-insider-confidenc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4127","BULL","EOLS","VSXY","BULG","BK4094","BULU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657696349","title":"Evolus (EOLS) Stock Jumps On Margin Turn And EBITDA Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2657696349","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657696349?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:35","pubTimestamp":1786073717,"startTime":"0","endTime":"0","summary":"Evolus stock just ripped almost 20% higher to US$7.41, and the move is all about one thing. The market is latching onto a margin and profitability turn that feels very different from the company investors watched over the past year.\nQ2 revenue of US$84.1m, helped by aesthetics demand across toxins and fillers, arrived alongside a third straight quarter of positive adjusted earnings before interest, taxes, depreciation and amortization. That shift in earnings quality is what traders are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eols/evolus/news/evolus-eols-stock-jumps-on-margin-turn-and-ebitda-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eols/evolus/news/evolus-eols-stock-jumps-on-margin-turn-and-ebitda-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657049668","title":"Apyx Medical Q2 Revenue Beats Estimates on Surgical Aesthetics Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657049668","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657049668?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:40","pubTimestamp":1786048823,"startTime":"0","endTime":"0","summary":"Apyx Medical Q2 revenue beats estimates on surgical aesthetics growthOverviewSurgical aesthetics firm's Q2 revenue rose 22% yr/yr, beating analyst expectationsQ2 adjusted EBITDA loss narrowed and beat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMD","BK4198","LU2324357040.USD","BK4585","EOLS","APYX","BK4588","ESTA","BK4082","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639344","title":"Establishment Labs Q2 Revenue Rises, Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639344","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639344?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:10","pubTimestamp":1786018256,"startTime":"0","endTime":"0","summary":"Establishment Labs Q2 revenue rises, beats estimatesOverviewGlobal breast aesthetics device maker's Q2 revenue grew yr/yr, beating analyst expectationsCompany raised full-year revenue guidance, citing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL","BK4082","BK4007","ESTA","BK4588","INMD","BK4198","BK4585","EOLS","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657450189","title":"Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657450189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657450189?lang=en_us&edition=fundamental","pubTime":"2026-08-06 12:45","pubTimestamp":1785991546,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Evolus yesterday and set a price target of $15.00. The company’s shares closed yesterda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-evolus-eols-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-evolus-eols-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657132577","title":"Evolus Inc. Earnings Call Signals Confident Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657132577","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657132577?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:08","pubTimestamp":1785974936,"startTime":"0","endTime":"0","summary":"Evolus, Inc. (($EOLS)) has held its Q2 earnings call. Read on for the main highlights of the call. Evolus, Inc. struck a confident tone on its late...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evolus-inc-earnings-call-signals-confident-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evolus-inc-earnings-call-signals-confident-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657557447","title":"Evolus Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657557447","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657557447?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:43","pubTimestamp":1785969805,"startTime":"0","endTime":"0","summary":"Evolus Inc reports results for the quarter ended June 30 - Earnings SummaryEvolus IncEOLS.OQreported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, higher than the sam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571212","title":"Evolus Posts Scientific Investor Presentation on Jeuveau, Evolysse HA Fillers, Profhilo Skin-Quality Injectable Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571212","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571212?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:12","pubTimestamp":1785967945,"startTime":"0","endTime":"0","summary":"Evolus posts scientific investor presentation on Jeuveau, Evolysse HA fillers, Profhilo skin-quality injectable portfolioEvolus highlighted a broader aesthetics portfolio built around Jeuveau neurotox","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL854ZgY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657575913","title":"Evolus Q2 Revenue Rises 21%, Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657575913","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657575913?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:48","pubTimestamp":1785962939,"startTime":"0","endTime":"0","summary":"Evolus Q2 revenue rises 21%, lifts 2026 outlookOverviewUS injectable aesthetics firm's Q2 revenue grew 21% yr/yr, driven by market share gainsCompany delivered third consecutive quarter of positive ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0566484027.USD","LU1242518857.USD","LU1559883803.SGD","BK4082","BK4007","BK4588","INMD","LU1242518931.SGD","ELF","LU0979878070.USD","BK4585","EOLS","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657257804","title":"Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657257804","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657257804?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:28","pubTimestamp":1785961698,"startTime":"0","endTime":"0","summary":"Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 0 percent. This is a 47.83 percent increase over losses of $(0.23) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60972857/evolus-q2-eps-0-12-sales-84-084m-beat-81-603m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578294","title":"Evolus Q2 GAAP Operating Loss Narrows to USD 4.5 Million; Revenue Increases 21% to USD 84.1 Million vs Year-Ago Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578294","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578294?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:25","pubTimestamp":1785961502,"startTime":"0","endTime":"0","summary":"Evolus Q2 GAAP operating loss narrows to USD 4.5 million; revenue increases 21% to USD 84.1 million vs year-ago quarterEvolus Q2 net revenue rose 21% to USD 84.1 million; GAAP net loss narrowed to USD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL1RRXf3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520860","title":"Evolus Q2 Product Revenue USD 83.35 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520860","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520860?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:06","pubTimestamp":1785960361,"startTime":"0","endTime":"0","summary":"BRIEF-Evolus Q2 Product Revenue USD 83.35 MillionAug 05 (Reuters) - Evolus Q2 net income USD -8.052 million.Q2 gross profit USD 57.18 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXGCMMJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578302","title":"Evolus Outlook FY Sales Growth 11-13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578302?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:05","pubTimestamp":1785960303,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXGCMMJL:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657357837","title":"Evolus Outlook FY Sales USD 330-337 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657357837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657357837?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:05","pubTimestamp":1785960303,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXGCMMJL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556277","title":"Evolus expands strategic partnership with Symatese to commercialize Estyme","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556277","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556277?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:35","pubTimestamp":1785846944,"startTime":"0","endTime":"0","summary":"Evolus (EOLS) announced it has expanded its partnership with Symatese through an amendment to the companies’ existing licensing and distribution ag...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolus-expands-strategic-partnership-with-symatese-to-commercialize-estyme-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolus-expands-strategic-partnership-with-symatese-to-commercialize-estyme-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656655663","title":"Evolus Expands Symatese Partnership to Commercialize Estyme HA Gels in Canada, Australia, New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2656655663","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656655663?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:31","pubTimestamp":1785846701,"startTime":"0","endTime":"0","summary":"Evolus expands Symatese partnership to commercialize Estyme HA gels in Canada, Australia, New ZealandEvolus expanded its partnership with Symatese, securing exclusive rights to commercialize Estyme in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL211KfR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656955653","title":"Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2656955653","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656955653?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:30","pubTimestamp":1785846601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA59CLV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556572","title":"Evolus - Agreement Expected to be Accretive to Evolus International Gross Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556572?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:30","pubTimestamp":1785846601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA59CLV7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556571","title":"Evolus - to Commercialize Estyme in All Markets with Jeuveau and Nuceiva in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556571?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:30","pubTimestamp":1785846601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA59CLV7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EOLS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evolus.com","stockEarnings":[{"period":"1week","weight":0.0972},{"period":"1month","weight":0.5008},{"period":"3month","weight":0.4523},{"period":"6month","weight":0.9989},{"period":"1year","weight":0.2079},{"period":"ytd","weight":0.3496}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.1111},{"period":"1year","weight":0.1921},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.240689},{"month":2,"riseRate":0.625,"avgChangeRate":0.185525},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.106703},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.036367},{"month":5,"riseRate":0.777778,"avgChangeRate":0.303421},{"month":6,"riseRate":0.666667,"avgChangeRate":0.016455},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024131},{"month":8,"riseRate":0.444444,"avgChangeRate":0.09718},{"month":9,"riseRate":0.25,"avgChangeRate":-0.131057},{"month":10,"riseRate":0.625,"avgChangeRate":-0.053423},{"month":11,"riseRate":0.5,"avgChangeRate":-0.016865},{"month":12,"riseRate":0.375,"avgChangeRate":-0.04679}],"exchange":"NASDAQ","name":"Evolus Inc.","nameEN":"Evolus Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evolus Inc.(EOLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evolus Inc.,EOLS,Evolus Inc.股票,Evolus Inc.股票老虎,Evolus Inc.股票老虎国际,Evolus Inc.行情,Evolus Inc.股票行情,Evolus Inc.股价,Evolus Inc.股市,Evolus Inc.股票价格,Evolus Inc.股票交易,Evolus Inc.股票购买,Evolus Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evolus Inc.(EOLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evolus Inc.(EOLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}